Pharmafile Logo
Pharmafocus logo
Advanced Search

Novo Nordisk

Showing 15 posts of 180 posts found.

novo_nordisk_new_hillerod_facility

Novo Nordisk expands in Denmark

September 8, 2015
Manufacturing and Production, Research and Development Denmark, Novo Nordisk, haemophilia API

Novo Nordisk has announced that the company is investing 500 million Danish kroner (about £48.8 million) in a new 19,000 …

News
massachusetts_institute_of_technology_7194419730

Novo joins forces with MIT innovating drug devices

September 8, 2015
Manufacturing and Production, Research and Development Novo Nordisk

Novo Nordisk has initiated a research collaboration with the Langer Laboratory at the Massachusetts Institute of Technology for what is …

News

Novo Nordisk to buy two pharma research companies

August 27, 2015
Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …

News
artist's impression

Novo Nordisk plans $2bn expansion of production facilities

August 26, 2015
Manufacturing and Production, Research and Development Novo Nordisk, manufacturing

Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …

News
novonordiskhq

Novo Nordisk abandons Victoza submission after mixed T1D results

August 26, 2015
Research and Development Novo Nordisk, Victoza, diabetes, insulin

Novo Nordisk has been forced to scrap plans to expand its licence for Victoza to include adults with type 1 …

News

Novo Nordisk pushes forward with new diabetes drug trial

July 13, 2015
Research and Development GLP-1 agonist, Novo Nordisk, diabetes, phase III, semaglutide, type 2 diabetes

Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …

News

Novo Nordisk pulls Tresiba in Germany after pricing row

July 6, 2015
Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access

Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …

News
peter_henshaw

The Partners hires creative director from InVentive

June 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw

Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team.  …

Appointment
EMA image

EMA waves through a raft of drug recommendations

June 26, 2015
Research and Development, Sales and Marketing AbbVie, Alexion, CHMP, EMA, Novartis, Novo Nordisk, brett wells

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …

News
Novo image

Novo Nordisk launches diabetes combination

June 8, 2015
Sales and Marketing Novo Nordisk, Xutolphy, ada, diabetes

Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …

News
screen_shot_2015-05-06_at_11

Lundbeck gains new chief executive from Novo Nordisk

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen

Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …

Appointment
Novo image

Novo Nordisk invests in haemophilia with Denmark facility

May 5, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven

Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …

News
Novo image

Novo Nordisk obesity drug is launched in the US

April 23, 2015
Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization

Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …

News
Novo image

Novo Nordisk opens insulin plant in Russia

April 10, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill

Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …

News
Novo image

FDA to look again at Novo Nordisk insulin submissions

April 8, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec

Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024